Petco Health and Wellness Stock (NASDAQ: WOOF)

Petco Health and Wellness (NASDAQ:WOOF) Stock, Quote.Headers.trade-ideas

Petco Health and Wellness

Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.

Wall Street, New York

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

WOOF

These Analysts Increase Their Forecasts On Petco Health and Wellness After Strong Q3 Results

Movers

AVGO

BNTX

CHWY

EXAS

FSLR

MSTR

ORCL

ROKU

SMMT

These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also raised price targets for Applovin and Arm Holdings. 

Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?


Petco Health and Wellness (NASDAQ:WOOF) stock price struggles are over. The steep 90% decline from peak to trough is over, and a bottom is in place, with a full technical reversal soon to follow. The reversal in price

The Squeeze is on for Petco Stock, Buy it When the Dust Settles

Petco Health and Wellness Company, Inc. - Class A Common Stock

Petco Health and Wellness Co Inc

<h3>Gainers</h3>
<ul>
<li><strong>Jeffs Brands</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) stock increased by 38.6% to $3.19 during Friday's pre-market session. The company's market cap stands at $2.2 million. </li>
<li><strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) stock moved upwards by 22.44% to $6.0. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li><strong>Color Star Tech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares rose 18.75% to $4.59. The market value of their outstanding shares is at $2.8 million. </li>
<li><strong>American Outdoor Brands</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) stock moved upwards by 12.01% to $12.21. The market value of their outstanding shares is at $156.7 million. The company's, Q2 earnings came out yesterday. </li>
<li><strong>Lululemon Athletica</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) shares moved upwards by 10.19% to $379.97. The market value of their outstanding shares is at $46.6 billion. The company's, Q3 earnings came out yesterday. </li>
<li><strong>Zumiez</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) stock increased by 9.17% to $22.01. The company's market cap stands at $421.3 million. As per the news, the Q3 earnings report came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Smith &amp; Wesson Brands</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) stock declined by 16.7% to $11.35 during Friday's pre-market session. The company's market cap stands at $509.0 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li><strong>Latham Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) stock fell 15.89% to $5.4. The market value of their outstanding shares is at $624.3 million. </li>
<li><strong>United Homes Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) stock fell 15.74% to $5.14. The company's market cap stands at $248.8 million. </li>
<li><strong>EpicQuest Education Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEIQ#NASDAQ">EEIQ</a>) shares decreased by 8.92% to $0.92. The company's market cap stands at $11.9 million. </li>
<li><strong>GigaCloud Tech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) shares declined by 8.7% to $22.15. The market value of their outstanding shares is at $907.5 million. </li>
<li><strong>Shoe Carnival</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) shares fell 8.23% to $30.0. The market value of their outstanding shares is at $814.7 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AOUT

EEIQ

JFBR

LULU

SCVL

SWBI

SWIM

ZUMZ

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<p><strong>Petco Health and Wellness Company, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported better-than-expected results for its <a href="https://www.benzinga.com/quote/WOOF/earnings">third quarter on Thursday.</a></p>
<p>The company posted a quarterly loss of 1 cents per share versus market estimates of a loss of 4 cents per share. The company reported quarterly sales of $1.51 billion which beat the analyst consensus estimate of $1.50 billion.</p>
<p>&#8220;Our third quarter results demonstrate the meaningful progress we&#8217;re making to strengthen our retail fundamentals to drive sustainable, profitable growth,&#8221; said Joel Anderson, Petco&#8217;s Chief Executive Officer. &#8220;While there is more work to do, our improving results increase our conviction that we are on the right path to position Petco to win long-term. Our entire organization is focused on driving profitability and free cash flow, and I&#8217;m confident we&#8217;re set up for a solid finish to 2024.&#8221;</p>
<p>Petco Health shares gained 16.9% to trade at $5.73 on Friday.</p>
<p>These analysts made changes to their price targets on Petco Health following earnings announcement.</p>
<ul>
<li>Wells Fargo analyst Zachary Fadem maintained Petco Health and Wellness with an Equal-Weight and raised the price target from $3 to $5.</li>
<li>RBC Capital analyst Steven Shemesh maintained the stock with an Outperform and boosted the price target from $5 to $6.</li>
<li>Morgan Stanley analyst Simeon Gutman maintained Petco Health and Wellness with an Equal-Weight and raised the price target from $3 to $6.</li>
<li>Wedbush analyst Seth Basham maintained Petco Health and Wellness with an Outperform and boosted the price target from $5.5 to $6.</li>
</ul>
<p><strong>Considering buying WOOF stock? Here&#8217;s what analysts think: </strong></p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="567" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-1024x567.png" alt="" class="wp-image-681107" style="width:571px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-1024x567.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454.png 1173w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/24/12/42364367/how-to-earn-500-a-month-from-oracle-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings</a></strong></li>
</ul>


<p>Wedbush  analyst Seth Basham   maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and raises the price target from $5.5 to $6.</p>


Wedbush Maintains Outperform on Petco Health and Wellness, Raises Price Target to $6

<p>Morgan Stanley  analyst Simeon Gutman   maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and raises the price target from $3 to $6.</p>


Morgan Stanley Maintains Equal-Weight on Petco Health and Wellness, Raises Price Target to $6

<p>RBC Capital  analyst Steven Shemesh   maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and raises the price target from $5 to $6.</p>


RBC Capital Maintains Outperform on Petco Health and Wellness, Raises Price Target to $6

WIIM

Petco Health shares are trading higher after Wells Fargo raised its price target on the stock from $3 to $5.

<p>7 analysts have expressed a variety of opinions on Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $4.36, a high estimate of $5.50, and a low estimate of $3.00. Witnessing a positive shift, the current average has risen by 10.1% from the previous average price target of $3.96.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1733497339_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>The standing of Petco Health and Wellness among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$5.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$5.50</td>
<td>$5.00</td>
</tr>
<tr>
<td>Steven Zaccone</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$4.50</td>
<td>$4.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$4.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$3.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$3.00</td>
<td>$2.75</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Petco Health and Wellness. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Petco Health and Wellness compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Petco Health and Wellness's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Petco Health and Wellness's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/WOOF/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Petco Health and Wellness analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Get to Know Petco Health and Wellness Better</h2>
<p>Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.</p>
<h3>Financial Milestones: Petco Health and Wellness's Journey</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Petco Health and Wellness's revenue growth over a period of 3 months has faced challenges. As of 31 July, 2024, the company experienced a revenue decline of approximately <strong>-0.46%</strong>. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Petco Health and Wellness's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-1.63%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Petco Health and Wellness's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>-2.16%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-0.47%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>2.64</strong>, Petco Health and Wellness faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Expert Ratings For Petco Health and Wellness

<p>Wells Fargo  analyst Zachary Fadem   maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and raises the price target from $3 to $5.</p>


Wells Fargo Maintains Equal-Weight on Petco Health and Wellness, Raises Price Target to $5

<p>The earnings results for <strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:02 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $17.00 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.</p>
<p>Here's a look at Petco Health and Wellness's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.</p>
<p>To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Petco Health and Wellness: Q3 Earnings Insights

Petco Health and Wellness shares are trading higher after the company announced better-than-expected Q3 financial results.

<p>The Q3 earnings report for <strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $17.00 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>The company missed on EPS by $0.0 in the previous quarter, leading to a 33.0% increase share price change the next day.</p>
<p>Here's a look at Petco Health and Wellness's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.</p>
<p>To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Summary: Petco Health and Wellness Q3

<p>The Q3 earnings report for <strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $17.00 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.</p>
<p>Here's a look at Petco Health and Wellness's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.</p>
<p>To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Petco Health and Wellness Q3 Earnings Assessment

<p><strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) announced its Q3 earnings on Thursday, December 5, 2024 at 04:02 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $17.00 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.</p>
<p>Here's a look at Petco Health and Wellness's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.</p>
<p>To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: Petco Health and Wellness Q3

<p>The earnings results for <strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:02 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $17.00 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company missed on EPS by $0.0 in the previous quarter, leading to a 33.0% increase share price change the next day.</p>
<p>Here's a look at Petco Health and Wellness's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.</p>
<p>To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Petco Health and Wellness Earnings Review: Q3 Summary

<p><strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported its Q3 earnings results on Thursday, December 5, 2024 at 04:02 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $17.00 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>During the previous quarter, the company missed on EPS by $0.0, leading to a 33.0% increase share price change the next day.</p>
<p>Here's a look at Petco Health and Wellness's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Insights into Petco Health and Wellness Q3 Earnings

<p><strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) just disclosed its Q3 earnings on Thursday, December 5, 2024 at 04:02 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $17.00 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>The company missed on EPS by $0.0 in the last quarter, resulting in a 33.0% increase share price change the following day.</p>
<p>Here's a look at Petco Health and Wellness's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Petco Health and Wellness Earnings Report: Q3 Overview

<p><strong>Fiscal Q4 2024 Outlook</strong></p>
<p>The company is providing Q4 guidance for revenue, Adjusted EBITDA, and Adjusted EPS, in addition to full year interest expense and capital expenditure expectations.</p>
<p>For Fiscal Q4 2024, the company expects:</p>
<p><figure class="table"><br />
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Metric&#x2A;</td>
<td colspan="1" rowspan="1">
<p>FQ4 2024</p>
<p>Guidance</p>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Revenue</td>
<td colspan="1" rowspan="1">~ $1.55 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">Between $90 million and $95 million, including a minimum of $10 million in third party consulting fees associated with our transformation effort</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EPS</td>
<td colspan="1" rowspan="1">Between $0.00 and $0.02</td>
</tr>
</tbody>
</table>
<p></p></figure>
</p><p>For Fiscal 2024 (a 52-week year), the company expects the following:</p>
<p><figure class="table"><br />
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Metric&#x2A;</td>
<td colspan="1" rowspan="1">
<p>2024</p>
<p>Guidance, YoY</p>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net interest expense</td>
<td colspan="1" rowspan="1">~$140 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">~$130 million</td>
</tr>
</tbody>
</table>
<p></p></figure>
</p><p>&#x2A;Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. For fiscal 2024, our guidance anticipates a 26 percent tax rate, and 273 million weighted average diluted share count. Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.</p>


Guidance

Petco Health and Wellness Company Sees Q4 Adj EPS $0.00-$0.02 Vs $0.04 Est.; Revenue ~$1.55B Vs $1.57B Est.

<p>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 60 percent increase over losses of $(0.05) per share from the same period last year.  The company reported quarterly sales of $1.51 billion which beat the analyst consensus estimate of $1.50 billion by 0.76 percent.  This is a 1.17 percent increase over sales of $1.49 billion the same period last year.</p>


Earnings Beats

Petco Health and Wellness Q3 Adj $(0.02) Beats $(0.04) Estimate, Sales $1.51B Beat $1.50B Estimate

<h3>Companies Reporting Before The Bell</h3>
<p>• John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLY#NYSE">WLY</a>) is likely to report quarterly earnings at $0.70 per share on revenue of $420.00 million. </p>
<p>• America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) is projected to report quarterly loss at $0.10 per share on revenue of $344.37 million. </p>
<p>• Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) is expected to report quarterly earnings at $2.16 per share on revenue of $1.93 billion. </p>
<p>• Patterson Cos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDCO#NASDAQ">PDCO</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $1.65 billion. </p>
<p>• Methode Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NYSE">MEI</a>) is estimated to report quarterly loss at $0.16 per share on revenue of $268.46 million. </p>
<p>• Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) is projected to report quarterly earnings at $0.33 per share on revenue of $1.37 billion. </p>
<p>• Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) is estimated to report quarterly earnings at $0.94 per share on revenue of $10.14 billion. </p>
<p>• Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) is projected to report quarterly earnings at $1.21 per share on revenue of $675.35 million. </p>
<p>• Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $187.70 million. </p>
<p>• Lands' End (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LE#NASDAQ">LE</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $315.21 million. </p>
<p>• Hooker Furnishings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFT#NASDAQ">HOFT</a>) is projected to report quarterly earnings at $0.28 per share on revenue of $101.35 million. </p>
<p>• Toronto-Dominion Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TD#NYSE">TD</a>) is likely to report quarterly earnings at $1.28 per share on revenue of $10.26 billion. </p>
<p>• GMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) is projected to report quarterly earnings at $2.19 per share on revenue of $1.46 billion. </p>
<p>• Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) is expected to report quarterly loss at $0.12 per share on revenue of $1.71 billion. </p>
<p>• Duluth Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTH#NASDAQ">DLTH</a>) is expected to report quarterly loss at $0.32 per share on revenue of $134.93 million. </p>
<p>• Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) is projected to report quarterly earnings at $0.98 per share on revenue of $34.20 billion. </p>
<p>• Canadian Imperial Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CM#NYSE">CM</a>) is likely to report quarterly earnings at $1.26 per share on revenue of $4.67 billion. </p>
<p>• Caleres (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAL#NYSE">CAL</a>) is estimated to report quarterly earnings at $1.36 per share on revenue of $751.36 million. </p>
<p>• Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) is likely to report quarterly earnings at $1.73 per share on revenue of $5.98 billion. </p>
<p>• Brown Forman Inc Class B Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $1.07 billion. </p>
<p>• John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLYB#NYSE">WLYB</a>) is expected to report earnings for its second quarter. </p>
<p>• Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $113.40 million. </p>
<p>• Tuniu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOUR#NASDAQ">TOUR</a>) is likely to report earnings for its third quarter. </p>
<p>• Brown Forman Inc Class A Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is projected to report earnings for its second quarter. </p>
<h3>Companies Reporting After The Bell</h3>
<p>• Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) is likely to report quarterly earnings at $0.30 per share on revenue of $253.96 million. </p>
<p>• Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) is likely to report quarterly loss at $0.62 per share on revenue of $1.29 billion. </p>
<p>• UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $347.72 million. </p>
<p>• Smith &amp; Wesson Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $133.52 million. </p>
<p>• Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) is expected to report quarterly loss at $0.07 per share on revenue of $180.66 million. </p>
<p>• Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $222.04 million. </p>
<p>• Domo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOMO#NASDAQ">DOMO</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $77.55 million. </p>
<p>• Lakeland Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAKE#NASDAQ">LAKE</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $44.30 million. </p>
<p>• Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) is estimated to report quarterly earnings at $1.26 per share on revenue of $225.60 million. </p>
<p>• Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) is expected to report quarterly earnings at $2.72 per share on revenue of $2.36 billion. </p>
<p>• Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) is likely to report quarterly earnings at $1.58 per share on revenue of $684.34 million. </p>
<p>• Smartsheet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) is likely to report quarterly earnings at $0.30 per share on revenue of $283.87 million. </p>
<p>• GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $188.25 million. </p>
<p>• HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $163.39 million. </p>
<p>• Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) is likely to report quarterly loss at $0.32 per share on revenue of $140.84 million. </p>
<p>• Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) is projected to report quarterly earnings at $4.52 per share on revenue of $2.50 billion. </p>
<p>• Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) is likely to report quarterly loss at $0.40 per share on revenue of $217.53 million. </p>
<p>• Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) is projected to report quarterly loss at $0.03 per share on revenue of $1.50 billion. </p>
<p>• Samsara (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $310.56 million. </p>
<p>• DocuSign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) is expected to report quarterly earnings at $0.87 per share on revenue of $745.26 million. </p>
<p>• American Outdoor Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $53.23 million. </p>
<p>• Hewlett Packard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) is likely to report quarterly earnings at $0.56 per share on revenue of $8.26 billion. </p>
<p>• Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) is likely to report quarterly earnings at $1.00 per share on revenue of $1.03 billion. </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ASAN

CRMT

CSIQ

DLTH

DOCU

DOMO

GTLB

GWRE

HOFT

LAKE

PATH

PDCO

RBRK

SAIC

SMAR

TLYS

TOUR

ULTA

VEEV

VSCO

WLYB

Earnings Scheduled For December 5, 2024

<p>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) will release its quarterly earnings report on Thursday, 2024-12-05. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Petco Health and Wellness to report an <strong>earnings per share</strong> (EPS) of $-0.03.</p>
<p>Petco Health and Wellness bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $0.00, leading to a 32.9% increase in the share price the following trading session.</p>
<p>Here's a look at Petco Health and Wellness's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>33.0%</td>
<td>10.0%</td>
<td>-18.0%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1733320914_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Petco Health and Wellness were trading at $5.17 as of December 03. Over the last 52-week period, shares are up 50.29%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Opinions on Petco Health and Wellness</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Petco Health and Wellness.</p>
<p>Analysts have given Petco Health and Wellness a total of 6 ratings, with the consensus rating being Outperform. The average one-year price target is $4.25, indicating a potential 17.79% downside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Sally Beauty Holdings, Upbound Group and ODP, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>The prevailing sentiment among analysts is an Neutral trajectory for Sally Beauty Holdings, with an average 1-year price target of $13.75, implying a potential 165.96% upside.</li>
<li>As per analysts' assessments, Upbound Group is favoring an Neutral trajectory, with an average 1-year price target of $35.5, suggesting a potential 586.65% upside.</li>
<li>ODP is maintaining an Neutral status according to analysts, with an average 1-year price target of $28.0, indicating a potential 441.59% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Sally Beauty Holdings, Upbound Group and ODP, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Petco Health and Wellness</td>
<td>Outperform</td>
<td>-0.46%</td>
<td>$580.73M</td>
<td>-2.16%</td>
</tr>
<tr>
<td>Sally Beauty Holdings</td>
<td>Neutral</td>
<td>1.48%</td>
<td>$479.20M</td>
<td>7.97%</td>
</tr>
<tr>
<td>Upbound Group</td>
<td>Neutral</td>
<td>9.17%</td>
<td>$511.09M</td>
<td>5.11%</td>
</tr>
<tr>
<td>ODP</td>
<td>Neutral</td>
<td>-11.31%</td>
<td>$364M</td>
<td>6.63%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Petco Health and Wellness ranks at the bottom for Revenue Growth and Gross Profit, indicating lower performance in these areas compared to its peers. However, it ranks in the middle for Return on Equity, suggesting a moderate level of profitability relative to others. Overall, there is room for improvement in revenue generation and gross profit margins to align with industry peers.</p>
<h3>Get to Know Petco Health and Wellness Better</h3>
<p>Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.</p>
<h3>Key Indicators: Petco Health and Wellness's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Petco Health and Wellness's revenue growth over a period of 3 months has faced challenges. As of 31 July, 2024, the company experienced a revenue decline of approximately <strong>-0.46%</strong>. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Petco Health and Wellness's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-1.63%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Petco Health and Wellness's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-2.16%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-0.47%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Petco Health and Wellness's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>2.64</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<p><a href="https://www.benzinga.com/quote/WOOF/earnings"><strong>To track all earnings releases for Petco Health and Wellness visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Petco Health and Wellness

Petco Health and Wellness Company (WOOF – Research Report), the Consumer Cyclical sector company, was revisited by a Wall Street analyst yesterday....

Cautious Optimism for Petco Amid Strong Q3 Performance and Challenges Ahead

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Petco Health and Wellness Company (WOOF – Research Report)...

Analysts Offer Insights on Consumer Cyclical Companies: Petco Health and Wellness Company (WOOF), Ulta Beauty (ULTA) and Toll Brothers (TOL)

Analyst Zachary Fadem of Wells Fargo maintained a Hold rating on Petco Health and Wellness Company (WOOF – Research Report), boosting the price tar...

Cautious Optimism: Petco's Positive Q3 Performance Meets Uncertain Q4 Outlook

In a report released today, Simeon Gutman from Morgan Stanley assigned a Hold rating on Petco Health and Wellness Company (WOOF – Research Report),...

Petco Health's Strategic Initiatives Signal Stability Amid Profitability Concerns, Justifying Hold Rating

Morgan Stanley analyst Simeon Gutman raised the firm's price target on Petco (WOOF) to $6 from $3 and keeps an Equal Weight rating on the shares. T...

Petco price target raised to $6 from $3 at Morgan Stanley

Wells Fargo raised the firm's price target on Petco (WOOF) to $5 from $3 and keeps an Equal Weight rating on the shares. Petco's Q3 update screens ...

Petco price target raised to $5 from $3 at Wells Fargo

Wedbush analyst Seth Basham raised the firm's price target on Petco (WOOF) to $6 from $5.50 and keeps an Outperform rating on the shares. Petco's Q...

Petco price target raised to $6 from $5.50 at Wedbush

RBC Capital raised the firm's price target on Petco (WOOF) to $6 from $5 and keeps an Outperform rating on the shares. The company reported another...

Petco price target raised to $6 from $5 at RBC Capital

Evercore ISI raised the firm's price target on Petco (WOOF) to $6 from $5 and keeps an In Line rating on the shares. The company's Q3 results were ...

Petco price target raised to $6 from $5 at Evercore ISI

Evercore ISI analyst Oliver Wintermantel has maintained their neutral stance on WOOF stock, giving a Hold rating today. Oliver Wintermantel's ratin...

Petco's Mixed Performance: Strong Q3 with Growth in Veterinary Services Amid Ongoing Challenges

Press Releases

Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS

Legal

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Petco Health and Wellness Company, Inc. - WOOF

Petco Health and Wellness Company, Inc. Investors: Company Investigated by the Portnoy Law Firm

Petco Names Joel D. Anderson as Chief Executive Officer

Petco Health + Wellness Company, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Petco Health and Wellness Company, Inc. to Host Second Quarter 2024 Earnings Conference Call on September 10, 2024

Petco Health + Wellness Company, Inc. Reports Second Quarter 2024 Earnings Results

Petco Health and Wellness Company, Inc. to Host Third Quarter 2024 Earnings Conference Call on December 5, 2024

Petco Names Joe Venezia Chief Revenue Officer

Petco Health + Wellness Company, Inc. Reports Third Quarter 2024 Earnings Results

DYAI

VTAK

Academy Sports and Outdoors, Inc. - Common Stock

Academy Sports

BARK

Build-A-Bear Workshop

Bath & Body Works

Barnes & Noble Education, Inc Common Stock

Barnes & Noble Education

Chewy

Dick's Sporting Goods

Envela

National Vision Holdings, Inc. - Common Stock

National Vision Holdings

Five Below

1-800-FLOWERS.COM, Inc. - Class A Common Stock

1-800-Flowers.com

Fitell

MarineMax

Leslies

PetMed Express

Sally Beauty Holdings, Inc. (Name to be changed from Sally Holdings, Inc.) Common Stock

Comments

Petco Health and Wellness

Petco Health and Wellness (WOOF) Forecast

Petco Health and Wellness (NASDAQ:WOOF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga